- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05550064
Structured Contraceptive Counseling During Pregnancy
Evaluating Effects of Prepartum Structured Contraceptive Counseling to Increase Postpartum Use of Long-acting Reversible Contraception
Unintended pregnancy is common among women of fertile age, and also among those who have recently given birth. A Swedish study has shown that about 7.7% experience a new pregnancy, and that 2.5% will have an abortion between 12-24 months from childbirth.
This is a prospective observational intervention study, aiming to evaluate the effects of structured contraceptive counseling during pregnancy on uptake of contraception postpartum and more specifically on long-acting reversible contraceptive methods, and to identify and explore the provider's and patient's experiences of structured contraceptive counseling during pregnancy.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Niklas Envall, PhD
- Phone Number: +46704090925
- Email: nen@du.se
Study Locations
-
-
-
Falun, Sweden
- Recruiting
- Health Care Region Dalarna
-
Contact:
- Sara Hogmark, MD
-
Karlstad, Sweden
- Recruiting
- Health Care Region Värmland
-
Contact:
- Karin Ängeby, PhD
-
Uppsala, Sweden
- Recruiting
- Health Care Region Uppsala
-
Contact:
- Lena Axén, RNM
-
Örebro, Sweden
- Recruiting
- Health Care Region Örebro Län
-
Contact:
- Yvonne Skogsdal, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years or older, gestational week 30 or more, need for contraception 6 months or more after delivery
Exclusion Criteria:
- Language barrier that affects participation when an interpreter is not available, assisted fertilization, planned sterilization of partner, use of contraception for other purposes than pregnancy prevention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention arm
Evidence-based intervention for SCC, previously evaluated in a cluster randomized trial (doi:10.1111/1471-0528.16754) The intervention for prepartum SCC will consist of four different parts, adjusted to suit pregnant women with emphasis on immediate start when applicable:
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference in proportions of LARC use 6 months postpartum among women receiving structured contraceptive counseling compared to standard care during pregnancy.
Time Frame: 6 months post partum
|
Percentage
|
6 months post partum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
New pregnancy
Time Frame: 6, 12, 18, and 24 months postpartum
|
Categorical (yes/no)
|
6, 12, 18, and 24 months postpartum
|
Outcome of new pregnancy
Time Frame: 6, 12, 18, nd 24 months postpartum
|
Categorical (yes/no) for planing to keep; kept; misscarriage; ectopic pregnancy; planning abortion; had an abotion
|
6, 12, 18, nd 24 months postpartum
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Niklas Envall, PhD, Dalarna University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SPR1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraception
-
Virginia Commonwealth UniversityCompletedPregnancy Related | Contraception | Contraception Behavior | Contraception Use
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Medical University of South CarolinaSociety of Family PlanningCompletedContraception | Contraception BehaviorUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedFemale Contraception | ContraceptionUnited States, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Montefiore Medical CenterSociety of Family PlanningCompletedContraception | Breastfeeding | Postpartum ContraceptionUnited States
Clinical Trials on Structured contraceptive counseling
-
Seva FoundationQueen's University, Belfast; Lumbini Eye Institute and Hospital; Indian Institute... and other collaboratorsCompletedDiabetes | Diabetic RetinopathyNepal
-
Columbia UniversityCompletedContraceptionUnited States
-
Swiss Tropical & Public Health InstituteUniversity of Basel; Ministry of Health, Lesotho; SolidarMedCompletedHIV/AIDS | Adherence, MedicationLesotho
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Family Care Health Centers; Memphis... and other collaboratorsCompletedContraception | Unintended PregnancyUnited States
-
Luis GuerraInstituto de Salud Carlos IIICompleted
-
Stanford UniversityTerminatedOverweight | Miscarriage | Obese | Recurrent Pregnancy LossUnited States
-
UNITI ConsortiumCharite University, Berlin, Germany; KU Leuven; National and Kapodistrian University... and other collaboratorsCompleted
-
KU LeuvenFund for Scientific Research, Flanders, Belgium; International Society for...Completed
-
Nordsjaellands HospitalUniversity of Copenhagen; University of Aarhus; Deakin University; Technical University... and other collaboratorsCompletedPhysical Activity | Pregnancy RelatedDenmark